Document is current

Any future updates will be listed below

Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease

Crossref DOI link: https://doi.org/10.1186/s13023-017-0692-3

Published Online: 2017-08-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark